Skip to main content

S. 2608

Referred to Committee

Reducing Opioid Risk Act

Introduced 3/22/2018•115th Congress•Senate

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

3/22/2018 • Senate

Summary

Reducing Opioid Risk Act

This bill amends the Federal Food, Drug, and Cosmetic Act to expand the authority of the Food and Drug Administration to require a drug manufacturer to inform health care providers about state and federal regulations for controlled substances, including the partial fill option.

Introduced in Senate • 3/22/2018

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Drug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesHealth personnelPrescription drugs

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (2)

Party Breakdown

1
Democrats
1
Republicans
0
Independents

Sponsor

S[
Sen. Warren, Elizabeth [D-MA]

Democrat • MA

Sponsored 3/22/2018

Cosponsors (1)

S[

Bill Journey

Originated in the Senate

Introduced

March 22, 2018

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committee Review

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in Senate3/22/2018

Details

Bill TypeS
Current StatusReferred to Committee
Cosponsors1